1% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1466

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for 1% Lidocaine Hci (NDC 51662-1466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (51662-1466-1 50 mL VIAL SERIALIZED LABELING)

1% Lidocaine HCl injection solution, USP, 500 mg/50 mL (10 mg/mL), multiple-dose vial with a purple cap. The label indicates the product is for prescription use, distributed by HF Acquisition Co LLC, and includes lot and expiration date information.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTTION 1)

Label for 1% Lidocaine HCl Injection, USP, 500 mg/50 mL (10 mg/mL) multiple-dose solution. The 50 mL vial is for infiltration and nerve block use, not for epidural or caudal use, and contains preservatives. Distributed by Hospira, Inc., Lake Forest, IL. Includes lot and expiration date placeholders and a barcode.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 2)

1% Lidocaine HCl Injection, USP label, 500 mg/50 mL (10 mg/mL) multiple-dose vial. Distributed by Hospira, Inc., Lake Forest, IL. The label states it is for infiltration and nerve block, not for epidural or caudal use, includes warnings, NDC 0409-4276-17, and storage instructions.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 3)

Label for 1% Lidocaine HCl Injection, USP, a multiple-dose 50 mL solution vial containing 500 mg (10 mg/mL) of lidocaine hydrochloride. The product is intended for infiltration and nerve block use, not for epidural or caudal use, and contains a preservative. It is labeled by Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 4)

Label for 1% Lidocaine HCl Injection, USP, 500 mg/50 mL (10 mg/mL) multiple-dose vial. The product is for infiltration and nerve block, explicitly not for epidural and caudal use. Contains preservatives including methylparaben. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 5)

Label for 1% Lidocaine HCI Injection, USP, containing 500 mg/50 mL (10 mg/mL) in a 50 mL multiple-dose vial. The label states it is for infiltration and nerve block, not for epidural or caudal use, and contains preservatives. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

51662 1466 2 Pouch Labeling

Label for 1% Lidocaine HCl Injection, USP 500mg/50mL (10mg/mL) in a 50mL vial. The label includes the NDC 51662-1466-2, lot number 123456, and expiration date 2030-01-01. It states use for infiltration and nerve block, and notes storage conditions and manufacturing details by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

51662 1466 3 Box Labeling

Label for 1% LIDOCAINE HCI Injection, USP 500 mg/50 mL (10 mg/mL) in a 50 mL vial. The label includes the NDC 51662-1466-3, lot number 123456, and expiration date 2030-01-01. It states use for infiltration and nerve block, not for epidural or caudal use, and notes the product is sterile and contains preservative. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

51662 1466 3 Serialized Labeling

A rectangular white label displaying barcoded information including GTIN (00351662146637), lot number, and expiration date. The label instructs to see the manufacturer's package insert and shows distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275. It includes the text 'RX ONLY' along the right side.*

FDA Label Image

Alt 2 Vial Label

Label for 1% Lidocaine HCl Injection, USP, 500 mg per 50 mL (10 mg/mL) multiple-dose solution. The label indicates use for infiltration and nerve block with prescription only. Distributed by Hospira, Inc. The package size is 50 mL.*

FDA Label Image

Alt 3 Vial Label

Label for 1% Lidocaine HCl Injection, USP, 500 mg/50 mL (10 mg/mL) multiple-dose vial. The label includes dosage strength, volume (50 mL), route (injection), and usage notes for infiltration and nerve block. It also displays the NDC number 0409-4276-17 and manufacturer information for Hospira, including locations, along with storage instructions and lot/expiration date fields.*

FDA Label Image

Alt Vial Label

The image shows a 50 mL multi-dose vial label for 1% Lidocaine HCl Injection, USP, with a strength of 500 mg/50 mL (10 mg/mL). The label states the product is for infiltration and nerve block use only and contains a list of inactive ingredients and storage instructions. The label also includes the NDC 0409-4276-17 and is distributed by Hospira, Inc., Lake Forest, IL, USA, with Pfizer Inc. mentioned at the bottom left in the template area.*

FDA Label Image

Description (Description)

A table displaying concentrations of lidocaine HCl and sodium chloride by percentage. Columns show 0.5%, 1%, 1.5%, and 2% lidocaine HCl with corresponding mg/mL values of 5, 10, 15, and 20 respectively. Sodium chloride concentrations decrease from 8 to 6 mg/mL across these percentages.*

FDA Label Image

D And A 1 (Dosage And Administration 1)

A table listing vial and ampul sizes for 1%, 1.5%, and 2% concentrations of lidocaine hydrochloride. It shows 30 mL single-dose teartop vials for 1%, 20 mL single-dose ampuls for 1.5%, and 10 mL single-dose ampuls for 2%.*

FDA Label Image

D And A 2 (Dosage And Administration 2)

Table presenting dosage information for Lidocaine Hydrochloride Injection, USP without epinephrine. It details procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, with columns for concentration (%), volume (mL), and total dose (mg). Various procedures include percutaneous, intravenous regional, brachial, dental, intercostal, paravertebral, pudendal, paracervical, obstetrical analgesia, cervical, lumbar, epidural, thoracic, caudal, and surgical anesthesia.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table listing various units of sale and concentrations of a drug product. It includes NDC codes, packaging details such as trays or cartons of glass ampuls and teartop vials, and concentration strengths ranging from 0.5% to 2% with corresponding milligram per milliliter values.*

FDA Label Image

How Supplied 2 (How Supplied 2)

This image shows tables listing unit of sale and concentration details for multiple NDC codes of lidocaine injection solutions. It includes packaging types such as bundles of ampuls and trays of plastic fliptop vials, with concentrations ranging from 0.5% to 2% and varying total milligrams per vial or bundle volume.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A table categorizing various drug classes alongside examples of drugs within each class. Drug classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with specific examples listed under each category.*

FDA Label Image

Superseeded Vial Label

Label for 1% Lidocaine HCl Injection, USP, 500 mg per 50 mL (10 mg/mL) solution. The label indicates a 50 mL multiple-dose vial, intended for infiltration and nerve block use. It notes the presence of preservatives and cautions against epidural and caudal use. Manufactured by Hospira, Inc.*

FDA Label Image

Structure (Structure)

Chemical structure of 1% Lidocaine HCl, showing a substituted aromatic ring with methyl groups, an amide linkage, and the hydrochloride and water components.*

FDA Label Image

Vial Label

Label for 1% Lidocaine HCl Injection, USP, showing a 50 mL multiple-dose vial with strength of 500 mg/50 mL (10 mg/mL). The label indicates use for infiltration and nerve block, lists NDC 0409-4276-17, and includes a warning that it is not for epidural and caudal use and contains preservatives. Distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.